Series A+ Fundraising and Investor Board Dynamics

Seed-stage fundraising, covered in the companion lesson Funding Vehicles, often runs on SAFEs or convertible notes: fast, lightweight instruments that defer most of the hard governance questions. Series A is where that changes: it's typically a real priced round, with institutional venture investors, actual preferred stock with real negotiated rights, a board seat or two for investors, and ongoing governance obligations that didn't exist before. This is the point where "raising money" starts to mean "taking on a real, ongoing governance partner," not just "getting a check."

As of 2026, the median Series A round is roughly $15 million, at a median post-money valuation around $78.7 million, though this varies significantly by sector. Pre-money valuation ranges commonly run $25M to $50M for B2B SaaS, $50M to $150M for AI, and $20M to $40M for fintech. Most Series A investors end up owning roughly 20 to 25% of the company after the round closes.

Why sector benchmarking matters: comparing your round to an unrelated industry's typical size or valuation can badly mislead your expectations in either direction. An AI company and a traditional SaaS company at "the same stage" can have very different typical Series A profiles.

A liquidation preference determines who gets paid first, and how much, when the company is sold or liquidated. The current market standard (used in roughly 98% of venture deals) is a 1x non-participating preference: in an exit, the investor chooses either to take back their original investment amount first, or to convert to common stock and take their pro-rata share of the proceeds, not both.

Participating preferred stock lets the investor do both: take the preference amount back, and still participate in the remaining proceeds alongside common holders. This directly reduces what founders and employees receive, and it's now considered largely off-market for early-stage deals. Roughly 95% of current deals use non-participating terms. If a term sheet proposes participating preferred as a standard term rather than something specifically negotiated for unusual circumstances, that's worth treating as a real red flag to push back on, not a routine formality.

Protective provisions give investors veto rights over specific major company decisions, without requiring a majority ownership stake to have that power. They appear in over 90% of current venture deals, and typically cover things like: selling the company, issuing new equity (which could dilute the investor), amending the certificate of incorporation, and incurring debt above a defined threshold.

Why this isn't really about day-to-day control: protective provisions are narrowly scoped to fundamental, high-stakes decisions. They don't give investors a say in ordinary operating decisions. Their purpose is to prevent the board or founders from unilaterally taking an action that would significantly change the investor's position (like a fire-sale acquisition or issuing a huge new dilutive round) without investor buy-in.

A typical Series A board settles around 5 members: 2 founders, 2 investors, and 1 independent director. The independent director's selection matters more than it might seem: if investors effectively control who fills that seat, the board can function as a 3-2 investor-leaning majority even though it's nominally balanced. Understanding who actually gets to select the independent director, and under what process, is worth real attention when negotiating board composition. It's not just a formality slide in the term sheet.

Information rights typically require the company to provide investors with regular financial statements and other updates on an ongoing basis: a real, recurring operational obligation, not a one-time disclosure. Pro-rata rights give existing investors the right (not obligation) to participate in future funding rounds specifically to maintain their existing ownership percentage, meaning your next round's available allocation for new investors is effectively reduced by however much your existing investors choose to exercise this right.